Physician profile
Joseph Chan
NPI 1689634776
$1,347.58
in general payments reported to CMS, 2019-2025
10 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $63.08 · 2021: $348 · 2022: $165 · 2023: $72.58 · 2024: $214 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $656.93 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $169.86 | 2021 | |
| Sirtex Medical INC | $158.79 | 2024 | Sir-Spheres Microspheres |
| Ekos Corporation | $134.37 | 2019 | |
| Bard Peripheral Vascular, INC. | $114.49 | 2023-2024 | |
| Astellas Pharma US INC | $37.99 | 2020 | |
| Abbott Laboratories | $24.96 | 2025 | Diamondback Coronary |
| Angiodynamics, INC. | $22.24 | 2021 | |
| Boston Scientific Corporation | $14.39 | 2021 | |
| Teleflex LLC | $13.56 | 2023 | Arrow |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.